Table 3 Individual adverse events from total patient population (n = 9)
| Â | Grade 1 | Grade 2 | Grade 3 | Grade 4 | Tx-related |
|---|---|---|---|---|---|
Hematology | |||||
Platelets | 0 | 0 | 0 | 0 | 0 |
Hemoglobin | 1 | 0 | 0 | 0 | 0 |
Abnormal leukocyte | 1 | 0 | 0 | 0 | 0 |
Abnormal lymphopenia | 0 | 0 | 0 | 0 | 0 |
Abnormal neutrophils | 0 | 0 | 0 | 0 | 0 |
Non-hematology | |||||
Bilirubin | 0 | 0 | 0 | 0 | 0 |
AST | 0 | 0 | 0 | 0 | 0 |
ALT | 1 | 0 | 0 | 0 | 0 |
Sugar (AC) | 2 | 0 | 0 | 0 | 0 |